{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:07:03Z","timestamp":1779062823426,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100022794","name":"Love Your Sister","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100022794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008018","name":"VicGovAu | Victorian Cancer Agency","doi-asserted-by":"publisher","award":["MCRF21011"],"award-info":[{"award-number":["MCRF21011"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"DHAC | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2012196 and GNT2027459"],"award-info":[{"award-number":["GNT2012196 and GNT2027459"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","award":["IIRS0049"],"award-info":[{"award-number":["IIRS0049"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","award":["Melbourne Research Scholarship"],"award-info":[{"award-number":["Melbourne Research Scholarship"]}],"id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Syst Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Intratumoral heterogeneity (ITH) is fueling tumor progression in breast cancer, as specific clones present within a tumor may have a selective advantage to colonize distant organs and escape therapy. Accurate sampling of ITH is therefore a pressing challenge in clinical oncology to adequately predict recurrence and inform rational and personalized therapies. Here, we used genetic barcoding to track the spatiotemporal composition of human breast cancer clones in six preclinical models\u2014across two cell lines and four patient-derived xenografts (PDXs). This allowed a direct side-by-side quantitative comparison of both intra-tumor clonal composition and how that composition was reflected in needle biopsies and cell-free DNA (cfDNA). These analyses highlighted several biologically and clinically relevant findings. First, the use of barcoding revealed that clonal diversity in the center of non-necrotic primary tumors was significantly higher than in the periphery. Second, cfDNA barcode analysis suggested that DNA \u2018shedding\u2019 in the vasculature varied widely, not only depending on necrosis and tumor burden but also across models. Third, combining information captured in both solid and liquid biopsies can provide a more robust assessment of tumor clonal composition. Taken together, these results showcase the utility of these barcoded models to optimize the use of solid and liquid biopsies as surrogates of tumor heterogeneity.<\/jats:p>","DOI":"10.1038\/s44320-026-00194-w","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T10:02:22Z","timestamp":1770804142000},"page":"659-684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic barcoding uncovers the clonal makeup of solid and liquid biopsies and their ability to capture intra-tumoral heterogeneity"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8178-6441","authenticated-orcid":false,"given":"Antonin","family":"Serrano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3836-3299","authenticated-orcid":false,"given":"Tom S","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Berthelet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Ftouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1650-8007","authenticated-orcid":false,"given":"Farrah","family":"El-Saafin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elgene","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Charafe-Jauffret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7477-3837","authenticated-orcid":false,"given":"Christophe","family":"Ginestier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7046-8392","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Hollande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9218-9917","authenticated-orcid":false,"given":"Belinda","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah-Jane","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalin H","family":"Naik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8075-6275","authenticated-orcid":false,"given":"Delphine","family":"Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"194_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bbcan.2019.06.002","volume":"1872","author":"M Aleckovic","year":"2019","unstructured":"Aleckovic M, McAllister SS, Polyak K (2019) Metastasis as a systemic disease: molecular insights and clinical implications. Biochim Biophys Acta Rev Cancer 1872:89\u2013102","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"194_CR2","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1158\/2159-8290.CD-20-1311","volume":"11","author":"C Alix-Panabieres","year":"2021","unstructured":"Alix-Panabieres C, Pantel K (2021) Liquid biopsy: from discovery to clinical application. Cancer Discov 11:858\u2013873","journal-title":"Cancer Discov"},{"key":"194_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41586-018-0409-3","volume":"560","author":"U Ben-David","year":"2018","unstructured":"Ben-David U, Siranosian B, Ha G, Tang H, Oren Y, Hinohara K, Strathdee CA, Dempster J, Lyons NJ, Burns R et al (2018) Genetic and transcriptional evolution alters cancer cell line drug response. Nature 560:325\u2013330","journal-title":"Nature"},{"key":"194_CR4","doi-asserted-by":"publisher","first-page":"eabf4408","DOI":"10.1126\/sciadv.abf4408","volume":"7","author":"J Berthelet","year":"2021","unstructured":"Berthelet J, Wimmer VC, Whitfield HJ, Serrano A, Boudier T, Mangiola S, Merdas M, El-Saafin F, Baloyan D, Wilcox J et al (2021) The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile. Sci Adv 7:eabf4408","journal-title":"Sci Adv"},{"key":"194_CR5","doi-asserted-by":"publisher","first-page":"224ra224","DOI":"10.1126\/scitranslmed.3007094","volume":"6","author":"C Bettegowda","year":"2014","unstructured":"Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM et al (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6:224ra224","journal-title":"Sci Transl Med"},{"key":"194_CR6","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1200\/JCO.2009.27.2419","volume":"28","author":"G Bianchini","year":"2010","unstructured":"Bianchini G, Qi Y, Alvarez RH, Iwamoto T, Coutant C, Ibrahim NK, Valero V, Cristofanilli M, Green MC, Radvanyi L et al (2010) Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers. J Clin Oncol 28:4316\u20134323","journal-title":"J Clin Oncol"},{"key":"194_CR7","doi-asserted-by":"publisher","first-page":"e1007243","DOI":"10.1371\/journal.pcbi.1007243","volume":"15","author":"K Chkhaidze","year":"2019","unstructured":"Chkhaidze K, Heide T, Werner B, Williams MJ, Huang W, Caravagna G, Graham TA, Sottoriva A (2019) Spatially constrained tumour growth affects the patterns of clonal selection and neutral drift in cancer genomic data. PLoS Comput Biol 15:e1007243","journal-title":"PLoS Comput Biol"},{"key":"194_CR8","doi-asserted-by":"publisher","first-page":"e0230622","DOI":"10.1371\/journal.pone.0230622","volume":"15","author":"MS Cho","year":"2020","unstructured":"Cho MS, Park CH, Lee S, Park HS (2020) Clinicopathological parameters for circulating tumor DNA shedding in surgically resected non-small cell lung cancer with EGFR or KRAS mutation. PLoS ONE 15:e0230622","journal-title":"PLoS ONE"},{"key":"194_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT (2018) Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol 15:81\u201394","journal-title":"Nat Rev Clin Oncol"},{"key":"194_CR10","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa1213261","volume":"368","author":"SJ Dawson","year":"2013","unstructured":"Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF, Dunning MJ, Gale D, Forshew T, Mahler-Araujo B et al (2013) Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 368:1199\u20131209","journal-title":"N Engl J Med"},{"key":"194_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1126\/science.1253462","volume":"346","author":"EC de Bruin","year":"2014","unstructured":"de Bruin EC, McGranahan N, Mitter R, Salm M, Wedge DC, Yates L, Jamal-Hanjani M, Shafi S, Murugaesu N, Rowan AJ et al (2014) Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346:251\u2013256","journal-title":"Science"},{"key":"194_CR12","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3389\/fonc.2020.01254","volume":"10","author":"NL de Vries","year":"2020","unstructured":"de Vries NL, Mahfouz A, Koning F, de Miranda N (2020) Unraveling the complexity of the cancer microenvironment with multidimensional genomic and cytometric technologies. Front Oncol 10:1254","journal-title":"Front Oncol"},{"key":"194_CR13","doi-asserted-by":"crossref","unstructured":"Deng J, Thennavan A, Shah S, Bagdatlioglu E, Klar N, Heguy A, Marier C, Meyn P, Zhang Y, Labbe K et al (2020) Serial single-cell profiling analysis of metastatic TNBC during Nab-paclitaxel and pembrolizumab treatment. Breast Cancer Res Treat 185:85\u201394","DOI":"10.1007\/s10549-020-05936-4"},{"key":"194_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.lungcan.2019.06.021","volume":"134","author":"PN Ding","year":"2019","unstructured":"Ding PN, Becker TM, Bray VJ, Chua W, Ma YF, Lynch D, Po J, Luk AWS, Caixeiro N, de Souza P et al (2019) The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: a prospective study. Lung Cancer 134:187\u2013193","journal-title":"Lung Cancer"},{"key":"194_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07406-4","volume":"9","author":"GV Echeverria","year":"2018","unstructured":"Echeverria GV, Powell E, Seth S, Ge Z, Carugo A, Bristow C, Peoples M, Robinson F, Qiu H, Shao J et al (2018) High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer. Nat Commun 9:5079","journal-title":"Nat Commun"},{"key":"194_CR16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/nature13952","volume":"518","author":"P Eirew","year":"2015","unstructured":"Eirew P, Steif A, Khattra J, Ha G, Yap D, Farahani H, Gelmon K, Chia S, Mar C, Wan A et al (2015) Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. Nature 518:422\u2013426","journal-title":"Nature"},{"key":"194_CR17","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1007\/s00432-020-03267-x","volume":"146","author":"SM Esagian","year":"2020","unstructured":"Esagian SM, Grigoriadou G, Nikas IP, Boikou V, Sadow PM, Won JK, Economopoulos KP (2020) Comparison of liquid-based to tissue-based biopsy analysis by targeted next generation sequencing in advanced non-small cell lung cancer: a comprehensive systematic review. J Cancer Res Clin Oncol 146:2051\u20132066","journal-title":"J Cancer Res Clin Oncol"},{"key":"194_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13058-019-1235-8","volume":"21","author":"D Fernandez-Garcia","year":"2019","unstructured":"Fernandez-Garcia D, Hills A, Page K, Hastings RK, Toghill B, Goddard KS, Ion C, Ogle O, Boydell AR, Gleason K et al (2019) Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer. Breast Cancer Res: BCR 21:149","journal-title":"Breast Cancer Res: BCR"},{"key":"194_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.20517\/2394-4722.2018.10","volume":"4","author":"A Finzel","year":"2018","unstructured":"Finzel A, Sadik H, Ghitti G, Laes J-F (2018) The combined analysis of solid and liquid biopsies provides additional clinical information to improve patient care. J Cancer Metastasis Treat 4:21","journal-title":"J Cancer Metastasis Treat"},{"key":"194_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/14737140.2019.1537785","volume":"19","author":"C Fremd","year":"2019","unstructured":"Fremd C, Jaeger D, Schneeweiss A (2019) Targeted and immuno-biology driven treatment strategies for triple-negative breast cancer: current knowledge and future perspectives. Expert Rev Anticancer Ther 19:29\u201342","journal-title":"Expert Rev Anticancer Ther"},{"key":"194_CR21","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883\u2013892","journal-title":"N Engl J Med"},{"key":"194_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.trecan.2021.11.002","volume":"8","author":"P Gui","year":"2022","unstructured":"Gui P, Bivona TG (2022) Evolution of metastasis: new tools and insights. Trends Cancer 8:98\u2013109","journal-title":"Trends Cancer"},{"key":"194_CR23","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.tcb.2019.03.003","volume":"29","author":"K Hinohara","year":"2019","unstructured":"Hinohara K, Polyak K (2019) Intratumoral heterogeneity: more than just mutations. Trends Cell Biol 29:569\u2013579","journal-title":"Trends Cell Biol"},{"key":"194_CR24","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.trecan.2023.03.008","volume":"9","author":"KK Howland","year":"2023","unstructured":"Howland KK, Brock A (2023) Cellular barcoding tracks heterogeneous clones through selective pressures and phenotypic transitions. Trends Cancer 9:591\u2013601","journal-title":"Trends Cancer"},{"key":"194_CR25","doi-asserted-by":"crossref","unstructured":"Hu Z, Li Z, Ma Z, Curtis C (2020a) Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. Nat Genet 52:701\u2013708","DOI":"10.1038\/s41588-020-0628-z"},{"key":"194_CR26","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41588-020-0628-z","volume":"52","author":"Z Hu","year":"2020","unstructured":"Hu Z, Li Z, Ma Z, Curtis C (2020b) Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. Nat Genet 52:701\u2013708","journal-title":"Nat Genet"},{"key":"194_CR27","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.cell.2018.03.041","volume":"173","author":"C Kim","year":"2018","unstructured":"Kim C, Gao R, Sei E, Brandt R, Hartman J, Hatschek T, Crosetto N, Foukakis T, Navin NE (2018) Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing. Cell 173:879\u2013893 e813","journal-title":"Cell"},{"key":"194_CR28","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2147\/CMAR.S235777","volume":"12","author":"MJ Lee","year":"2020","unstructured":"Lee MJ, Hueniken K, Kuehne N, Lu L, Jiang SX, Id Said B, McCartney A, Gao Y, Liang M, Obuobi T et al (2020) Cancer patient-reported preferences and knowledge for liquid biopsies and blood biomarkers at a comprehensive cancer center. Cancer Manag Res 12:1163\u20131173","journal-title":"Cancer Manag Res"},{"key":"194_CR29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41559-023-02000-4","volume":"7","author":"MA Lewinsohn","year":"2023","unstructured":"Lewinsohn MA, Bedford T, Muller NF, Feder AF (2023) State-dependent evolutionary models reveal modes of solid tumour growth. Nat Ecol Evol 7:581\u2013596","journal-title":"Nat Ecol Evol"},{"key":"194_CR30","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/s41592-021-01203-6","volume":"18","author":"SM Lewis","year":"2021","unstructured":"Lewis SM, Asselin-Labat ML, Nguyen Q, Berthelet J, Tan X, Wimmer VC, Merino D, Rogers KL, Naik SH (2021) Spatial omics and multiplexed imaging to explore cancer biology. Nat Methods 18:997\u20131012","journal-title":"Nat Methods"},{"key":"194_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-021-00165-4","volume":"5","author":"A Li","year":"2021","unstructured":"Li A, Keck JM, Parmar S, Patterson J, Labrie M, Creason AL, Johnson BE, Downey M, Thomas G, Beadling C et al (2021) Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics. NPJ Precis Oncol 5: 28","journal-title":"NPJ Precis Oncol"},{"key":"194_CR32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.stemcr.2013.11.009","volume":"2","author":"S Liu","year":"2014","unstructured":"Liu S, Cong Y, Wang D, Sun Y, Deng L, Liu Y, Martin-Trevino R, Shang L, McDermott SP, Landis MD et al (2014) Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Rep 2:78\u201391","journal-title":"Stem Cell Rep"},{"key":"194_CR33","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","volume":"37","author":"A Marusyk","year":"2020","unstructured":"Marusyk A, Janiszewska M, Polyak K (2020) Intratumor heterogeneity: the rosetta stone of therapy resistance. Cancer Cell 37:471\u2013484","journal-title":"Cancer Cell"},{"key":"194_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08595-2","volume":"10","author":"D Merino","year":"2019","unstructured":"Merino D, Weber TS, Serrano A, Vaillant F, Liu K, Pal B, Di Stefano L, Schreuder J, Lin D, Chen Y et al (2019) Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer. Nat Commun 10:766","journal-title":"Nat Commun"},{"key":"194_CR35","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41586-024-08087-4","volume":"634","author":"CK Mo","year":"2024","unstructured":"Mo CK, Liu J, Chen S, Storrs E, Targino da Costa ALN, Houston A, Wendl MC, Jayasinghe RG, Iglesia MD, Ma C et al (2024) Tumour evolution and microenvironment interactions in 2D and 3D space. Nature 634:1178\u20131186","journal-title":"Nature"},{"key":"194_CR36","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.cels.2021.04.008","volume":"12","author":"J Moehlin","year":"2021","unstructured":"Moehlin J, Mollet B, Colombo BM, Mendoza-Parra MA (2021) Inferring biologically relevant molecular tissue substructures by agglomerative clustering of digitized spatial transcriptomes with multilayer. Cell Syst 12:694\u2013705 e693","journal-title":"Cell Syst"},{"key":"194_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9760","volume":"6","author":"M Murtaza","year":"2015","unstructured":"Murtaza M, Dawson SJ, Pogrebniak K, Rueda OM, Provenzano E, Grant J, Chin SF, Tsui DW, Marass F, Gale D et al (2015) Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. Nat Commun 6:8760","journal-title":"Nat Commun"},{"key":"194_CR38","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1158\/1535-7163.MCT-18-0174","volume":"17","author":"HM Naml\u00f8s","year":"2018","unstructured":"Naml\u00f8s HM, Boye K, Mishkin SJ, Bar\u00f8y T, Lorenz S, Bjerkehagen B, Stratford EW, Munthe E, Kudlow BA, Myklebost O et al (2018) Noninvasive detection of ctDNA reveals intratumor heterogeneity and is associated with tumor burden in gastrointestinal stromal tumor. Mol Cancer Ther 17:2473\u20132480","journal-title":"Mol Cancer Ther"},{"key":"194_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature09807","volume":"472","author":"N Navin","year":"2011","unstructured":"Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, Cook K, Stepansky A, Levy D, Esposito D et al (2011) Tumour evolution inferred by single-cell sequencing. Nature 472:90\u201394","journal-title":"Nature"},{"key":"194_CR40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41559-021-01615-9","volume":"6","author":"R Noble","year":"2022","unstructured":"Noble R, Burri D, Le Sueur C, Lemant J, Viossat Y, Kather JN, Beerenwinkel N (2022) Spatial structure governs the mode of tumour evolution. Nat Ecol Evol 6:207\u2013217","journal-title":"Nat Ecol Evol"},{"key":"194_CR41","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41591-019-0561-9","volume":"25","author":"AR Parikh","year":"2019","unstructured":"Parikh AR, Leshchiner I, Elagina L, Goyal L, Levovitz C, Siravegna G, Livitz D, Rhrissorrakrai K, Martin EE, Van Seventer EE et al (2019) Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers. Nat Med 25:1415\u20131421","journal-title":"Nat Med"},{"key":"194_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-03182-1","volume":"21","author":"S Pellecchia","year":"2023","unstructured":"Pellecchia S, Viscido G, Franchini M, Gambardella G (2023) Predicting drug response from single-cell expression profiles of tumours. BMC Med 21:476","journal-title":"BMC Med"},{"key":"194_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23394-4","volume":"12","author":"B Pereira","year":"2021","unstructured":"Pereira B, Chen CT, Goyal L, Walmsley C, Pinto CJ, Baiev I, Allen R, Henderson L, Saha S, Reyes S et al (2021) Cell-free DNA captures tumor heterogeneity and driver alterations in rapid autopsies with pre-treated metastatic cancer. Nat Commun 12:3199","journal-title":"Nat Commun"},{"key":"194_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-020-01353-1","volume":"37","author":"F Pesapane","year":"2020","unstructured":"Pesapane F, Suter MB, Rotili A, Penco S, Nigro O, Cremonesi M, Bellomi M, Jereczek-Fossa BA, Pinotti G, Cassano E (2020) Will traditional biopsy be substituted by radiomics and liquid biopsy for breast cancer diagnosis and characterisation? Med Oncol 37:29","journal-title":"Med Oncol"},{"key":"194_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1158\/2159-8290.CD-15-1283","volume":"6","author":"M Russo","year":"2016","unstructured":"Russo M, Siravegna G, Blaszkowsky LS, Corti G, Crisafulli G, Ahronian LG, Mussolin B, Kwak EL, Buscarino M, Lazzari L et al (2016) Tumor heterogeneity and lesion-specific response to targeted therapy in colorectal cancer. Cancer Discov 6:147\u2013153","journal-title":"Cancer Discov"},{"key":"194_CR46","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41568-022-00500-2","volume":"22","author":"A Serrano","year":"2022","unstructured":"Serrano A, Berthelet J, Naik SH, Merino D (2022) Mastering the use of cellular barcoding to explore cancer heterogeneity. Nat Rev Cancer 22:609\u2013624","journal-title":"Nat Rev Cancer"},{"key":"194_CR47","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/s42003-023-05167-5","volume":"6","author":"A Serrano","year":"2023","unstructured":"Serrano A, Weber T, Berthelet J, El-Saafin F, Gadipally S, Charafe-Jauffret E, Ginestier C, Mariadason JM, Oakes SR, Britt K et al (2023) Experimental and spontaneous metastasis assays can result in divergence in clonal architecture. Commun Biol 6:821","journal-title":"Commun Biol"},{"key":"194_CR48","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature10933","volume":"486","author":"SP Shah","year":"2012","unstructured":"Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, Turashvili G, Ding J, Tse K, Haffari G et al (2012) The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486:395\u2013399","journal-title":"Nature"},{"key":"194_CR49","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1158\/1078-0432.CCR-16-0825","volume":"23","author":"JA Shaw","year":"2017","unstructured":"Shaw JA, Guttery DS, Hills A, Fernandez-Garcia D, Page K, Rosales BM, Goddard KS, Hastings RK, Luo J, Ogle O et al (2017) Mutation analysis of cell-free DNA and single circulating tumor cells in metastatic breast cancer patients with high circulating tumor cell counts. Clin Cancer Res 23:88\u201396","journal-title":"Clin Cancer Res"},{"key":"194_CR50","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1016\/j.ejca.2004.08.021","volume":"40","author":"T Sorlie","year":"2004","unstructured":"Sorlie T (2004) Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. Eur J Cancer 40:2667\u20132675","journal-title":"Eur J Cancer"},{"key":"194_CR51","doi-asserted-by":"crossref","unstructured":"Stukowski A (2010) Visualization and analysis of atomistic simulation data with OVITO-the Open Visualization Tool. Model Simul Mater Sci Eng 18:015012","DOI":"10.1088\/0965-0393\/18\/1\/015012"},{"key":"194_CR52","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41576-019-0114-6","volume":"20","author":"S Turajlic","year":"2019","unstructured":"Turajlic S, Sottoriva A, Graham T, Swanton C (2019) Resolving genetic heterogeneity in cancer. Nat Rev Genet 20:404\u2013416","journal-title":"Nat Rev Genet"},{"key":"194_CR53","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3390\/cancers12040916","volume":"12","author":"E Vagia","year":"2020","unstructured":"Vagia E, Mahalingam D, Cristofanilli M (2020) The landscape of targeted therapies in TNBC. Cancers 12:916","journal-title":"Cancers"},{"key":"194_CR54","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41573-023-00688-4","volume":"22","author":"B Van de Sande","year":"2023","unstructured":"Van de Sande B, Lee JS, Mutasa-Gottgens E, Naughton B, Bacon W, Manning J, Wang Y, Pollard J, Mendez M, Hill J et al (2023) Applications of single-cell RNA sequencing in drug discovery and development. Nat Rev Drug Discov 22:496\u2013520","journal-title":"Nat Rev Drug Discov"},{"key":"194_CR55","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1073\/pnas.1813417116","volume":"116","author":"M van der Heijden","year":"2019","unstructured":"van der Heijden M, Miedema DM, Waclaw B, Veenstra VL, Lecca MC, Nijman LE, van Dijk E, van Neerven SM, Lodestijn SC, Lenos KJ et al (2019) Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts. Proc Natl Acad Sci USA 116:6140\u20136145","journal-title":"Proc Natl Acad Sci USA"},{"key":"194_CR56","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nature14971","volume":"525","author":"B Waclaw","year":"2015","unstructured":"Waclaw B, Bozic I, Pittman ME, Hruban RH, Vogelstein B, Nowak MA (2015) A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity. Nature 525:261\u2013264","journal-title":"Nature"},{"key":"194_CR57","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nature14403","volume":"520","author":"E Wagenblast","year":"2015","unstructured":"Wagenblast E, Soto M, Guti\u00e9rrez-\u00c1ngel S, Hartl CA, Gable AL, Maceli AR, Erard N, Williams AM, Kim SY, Dickopf S et al (2015) A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis. Nature 520:358\u2013362","journal-title":"Nature"},{"key":"194_CR58","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, Junankar S, Harvey K, Andersson A, Thennavan A, Wang C, Torpy JR, Bartonicek N et al (2021) A single-cell and spatially resolved atlas of human breast cancers. Nat Genet 53:1334\u20131347","journal-title":"Nat Genet"},{"key":"194_CR59","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/carcin\/bgx071","volume":"38","author":"F Yang","year":"2017","unstructured":"Yang F, Wang Y, Li Q, Cao L, Sun Z, Jin J, Fang H, Zhu A, Li Y, Zhang W et al (2017) Intratumor heterogeneity predicts metastasis of triple-negative breast cancer. Carcinogenesis 38:900\u2013909","journal-title":"Carcinogenesis"},{"key":"194_CR60","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nm.3886","volume":"21","author":"LR Yates","year":"2015","unstructured":"Yates LR, Gerstung M, Knappskog S, Desmedt C, Gundem G, Van Loo P, Aas T, Alexandrov LB, Larsimont D, Davies H et al (2015) Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat Med 21:751\u2013759","journal-title":"Nat Med"},{"key":"194_CR61","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/1878-0261.12456","volume":"13","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Xu Y, Gong Y, Zhang Y, Lu Y, Wang C, Yao R, Li P, Guan Y, Wang J et al (2019) Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancer. Mol Oncol 13:1033\u20131046","journal-title":"Mol Oncol"}],"container-title":["Molecular Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44320-026-00194-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44320-026-00194-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44320-026-00194-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T23:41:18Z","timestamp":1779061278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44320-026-00194-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":61,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,5]]}},"alternative-id":["194"],"URL":"https:\/\/doi.org\/10.1038\/s44320-026-00194-w","relation":{},"ISSN":["1744-4292"],"issn-type":[{"value":"1744-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"15 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}